J Corren

Summary

Publications

  1. ncbi request reprint Rhinitis therapy and the prevention of hospital care for asthma: a case-control study
    Jonathan Corren
    Allergy Research Foundation, Los Angeles, CA 90025, USA
    J Allergy Clin Immunol 113:415-9. 2004
  2. ncbi request reprint Hydrofluoroalkane formulations of inhaled corticosteroids for the treatment of asthma
    Michelle Zeidler
    Department of Pulmonary and Critical Care Medicine, University of California, Los Angeles, California 90025, USA
    Treat Respir Med 3:35-44. 2004
  3. ncbi request reprint Nasal response to natural cat allergen exposure is significantly greater in patients with rhinitis and asthma than in patients with rhinitis alone
    Jonathan Corren
    J Allergy Clin Immunol 115:202-3. 2005
  4. ncbi request reprint Effects of zafirlukast upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure
    J Corren
    Allergy Research Foundation, Inc, Los Angeles, California 90025, USA
    Ann Allergy Asthma Immunol 87:211-7. 2001
  5. ncbi request reprint Evaluation and treatment of asthma: an overview
    Jonathan Corren
    David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
    Am J Manag Care 11:S408-15; quiz S427-33. 2005
  6. ncbi request reprint Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis
    Jonathan Corren
    Allergy Research Foundation, Inc, Los Angeles, California 90025, USA
    Clin Ther 27:543-53. 2005
  7. doi request reprint Treating asthma in the new millennium
    J Corren
    University of California, Los Angeles, UCLA School of Medicine, USA
    Postgrad Med 108:45-53. 2000
  8. ncbi request reprint Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis
    Jonathan Corren
    Allergy Research Foundation, Los Angeles, California 90025, USA
    Ann Allergy Asthma Immunol 93:243-8. 2004
  9. ncbi request reprint Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma
    Jonathan Corren
    Allergy Research Foundation, Inc, Los Angeles, California 90023, USA
    Clin Ther 25:776-98. 2003
  10. ncbi request reprint Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients
    J Corren
    Allergy Research Foundation, Inc, Los Angeles, California 90023, USA
    Ann Allergy Asthma Immunol 87:405-11. 2001

Detail Information

Publications30

  1. ncbi request reprint Rhinitis therapy and the prevention of hospital care for asthma: a case-control study
    Jonathan Corren
    Allergy Research Foundation, Los Angeles, CA 90025, USA
    J Allergy Clin Immunol 113:415-9. 2004
    ..Although clinical trials have demonstrated that rhinitis therapy improves subjective and objective measures of asthma, it is uncertain whether treatment of allergic rhinitis significantly affects the frequency of asthma exacerbations...
  2. ncbi request reprint Hydrofluoroalkane formulations of inhaled corticosteroids for the treatment of asthma
    Michelle Zeidler
    Department of Pulmonary and Critical Care Medicine, University of California, Los Angeles, California 90025, USA
    Treat Respir Med 3:35-44. 2004
    ..Future studies, involving histopathologic and clinical endpoints, will be necessary to determine whether treatment with HFA solutions offers significant advantages over currently available therapies...
  3. ncbi request reprint Nasal response to natural cat allergen exposure is significantly greater in patients with rhinitis and asthma than in patients with rhinitis alone
    Jonathan Corren
    J Allergy Clin Immunol 115:202-3. 2005
  4. ncbi request reprint Effects of zafirlukast upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure
    J Corren
    Allergy Research Foundation, Inc, Los Angeles, California 90025, USA
    Ann Allergy Asthma Immunol 87:211-7. 2001
    ..However, it is unknown whether these drugs modulate airway inflammation after exposure to allergen in a natural setting...
  5. ncbi request reprint Evaluation and treatment of asthma: an overview
    Jonathan Corren
    David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA
    Am J Manag Care 11:S408-15; quiz S427-33. 2005
    ..Asthma is a chronic, inflammatory condition that requires diligent long-term follow-up. This article will address the diagnostic evaluation of patients with asthma and present an overview of drugs commonly used in treatment...
  6. ncbi request reprint Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis
    Jonathan Corren
    Allergy Research Foundation, Inc, Los Angeles, California 90025, USA
    Clin Ther 27:543-53. 2005
    ..Azelastine nasal spray and oral cetirizine are selective histamine H(1)-receptor antagonists that are approved in the United States for the treatment of seasonal allergic rhinitis (SAR)...
  7. doi request reprint Treating asthma in the new millennium
    J Corren
    University of California, Los Angeles, UCLA School of Medicine, USA
    Postgrad Med 108:45-53. 2000
    ..Also, the longer duration of action of some of the new agents allows weekly to monthly dosing, which may well enhance patient compliance...
  8. ncbi request reprint Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis
    Jonathan Corren
    Allergy Research Foundation, Los Angeles, California 90025, USA
    Ann Allergy Asthma Immunol 93:243-8. 2004
    ..Treatment with omalizumab has been shown to reduce serum free IgE concentrations and to have beneficial effects on allergic airway disease. However, its effect on IgE synthesis is unknown...
  9. ncbi request reprint Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma
    Jonathan Corren
    Allergy Research Foundation, Inc, Los Angeles, California 90023, USA
    Clin Ther 25:776-98. 2003
    ..HFA replaces the chlorofluorocarbon (CFC) propellant of the previous formulation, producing aerosols of smaller average particle size...
  10. ncbi request reprint Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients
    J Corren
    Allergy Research Foundation, Inc, Los Angeles, California 90023, USA
    Ann Allergy Asthma Immunol 87:405-11. 2001
    ..Inhaled corticosteroids are established as maintenance therapy for persistent asthma. A new aerosol formulation of flunisolide delivers a small particle size by using a hydrofluoroalkane (HFA) propellant with a built-in spacer...
  11. ncbi request reprint Immunomodulation of asthma: where do we stand?
    Jonathan Corren
    Allergy Research Foundation, 11620 Wilshire Boulevard, Suite 200 210, Los Angeles, CA 90025, USA
    Curr Allergy Asthma Rep 2:433-5. 2002
  12. ncbi request reprint Comparison of once-daily mometasone furoate versus once-daily budesonide in patients with moderate persistent asthma
    J Corren
    Allergy Research Foundation, Los Angeles, California 90025, USA
    Int J Clin Pract 57:567-72. 2003
    ..In conclusion, once-daily treatment in the morning with MF-DPI 440 microg significantly improved pulmonary function and asthma control compared with morning administration of BUD-DPI 400 microg and placebo...
  13. doi request reprint Safety and tolerability of omalizumab
    J Corren
    Allergy Research Foundation, Los Angeles, CA 90025, USA
    Clin Exp Allergy 39:788-97. 2009
    ..Omalizumab (Xolair) is a recombinant humanized monoclonal anti-IgE antibody with proven efficacy in patients with moderate-to-severe and severe persistent allergic (IgE-mediated) asthma...
  14. ncbi request reprint Relationship between nonallergic upper airway disease and asthma
    Jonathan Corren
    Department of Medicine, University of California, Los Angeles, California, USA
    Clin Allergy Immunol 19:101-14. 2007
    ..Finally, given this complex relationship between localized and systemic inflammation, it behooves all physicians to assess and treat rhinitis and sinusitis when they are present in patients with asthma...
  15. ncbi request reprint Review of azelastine nasal spray in the treatment of allergic and non-allergic rhinitis
    Christina Lee
    Department of Medicine, Division of Pulmonary and Critical Care Medicine, Section of Clinical Immunology and Allergy, University of California, Los Angeles, Los Angeles, CA, USA
    Expert Opin Pharmacother 8:701-9. 2007
    ..Given its unique pharmacologic properties and clinical profile, azelastine maintains an important role in the treatment of chronic rhinitis...
  16. ncbi request reprint Twelve-week, randomized, placebo-controlled, multicenter study of the efficacy and tolerability of budesonide and formoterol in one metered-dose inhaler compared with budesonide alone and formoterol alone in adolescents and adults with asthma
    Jonathan Corren
    Allergy Research Foundation, Los Angeles, CA 90025, USA
    Clin Ther 29:823-43. 2007
    ....
  17. ncbi request reprint Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily
    William Lumry
    AARA Research Center, Dallas, Texas 75231, USA
    Ann Allergy Asthma Immunol 99:267-72. 2007
    ..Azelastine hydrochloride nasal spray is available worldwide for the treatment of seasonal allergic rhinitis (SAR) and perennial allergic rhinitis. One spray per nostril twice daily is the most commonly recommended dose...
  18. doi request reprint Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy
    Jonathan Corren
    Allergy Research Foundation, Los Angeles, CA 90025, USA
    J Allergy Clin Immunol 121:506-11. 2008
    ..It is not known whether stopping or reducing the dose of omalizumab maintains adequate suppression of free IgE levels and IgE-mediated mast cell activation...
  19. pmc Clinical and biochemical effects of a combination botanical product (ClearGuard) for allergy: a pilot randomized double-blind placebo-controlled trial
    Jonathan Corren
    Allergy Research Foundation, Los Angeles, USA
    Nutr J 7:20. 2008
    ..The current study was conducted to determine the effects of these combined ingredients upon the nasal response to allergen challenge in patients with seasonal allergic rhinitis...
  20. doi request reprint A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects
    Kenneth Tripp
    Sepracor, Inc, Marlborough, MA 01752, USA
    J Allergy Clin Immunol 122:544-9. 2008
    ..The short-acting beta(2)-agonists levalbuterol and racemic albuterol are available for administration through a hydrofluoroalkane-134a (HFA) metered-dose inhaler (MDI)...
  21. ncbi request reprint The connection between allergic rhinitis and bronchial asthma
    Jonathan Corren
    Allergy Research Foundation, Los Angeles, California 90025, USA
    Curr Opin Pulm Med 13:13-8. 2007
    ..The relationship between allergic rhinitis and asthma has intrigued practicing physicians since the turn of the century. Investigations during the past two decades have led to an increased understanding of this relationship...
  22. ncbi request reprint Omalizumab is effective in the long-term control of severe allergic asthma
    Bobby Quentin Lanier
    Lanier Education and Research Network, Fort Worth, Texas, USA
    Ann Allergy Asthma Immunol 91:154-9. 2003
    ..Previous reports show that addition of omalizumab to standard therapy reduces asthma exacerbations and simultaneously decreases use of inhaled corticosteroids (ICSs) and rescue medication in patients with allergic asthma...
  23. ncbi request reprint Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure
    Tamara T Perry
    Division of Allergy and Immunology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA
    Ann Allergy Asthma Immunol 93:431-8. 2004
    ..Challenge with short-term exposure to airborne cat allergen in sensitized patients produces pulmonary function changes and rhinitis symptoms...
  24. ncbi request reprint Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine
    Craig F LaForce
    Carolina Allergy and Asthma Consultants, Raleigh, North Carolina 27607, USA
    Ann Allergy Asthma Immunol 93:154-9. 2004
    ..Currently available oral second-generation antihistamines do not provide adequate symptom relief for many allergy patients...
  25. ncbi request reprint Omalizumab, a recombinant humanized anti-IgE antibody, reduces asthma-related emergency room visits and hospitalizations in patients with allergic asthma
    Jonathan Corren
    Allergy Research Foundation, Inc, Los Angeles, Calif 90025, USA
    J Allergy Clin Immunol 111:87-90. 2003
    ..Prevention of serious asthma exacerbations is an important therapeutic goal in patients with asthma...
  26. ncbi request reprint Small airways response to naturalistic cat allergen exposure in subjects with asthma
    Michelle R Zeidler
    Division of Pulmonary, David Geffen School of Medicine and Allergy Research Foundation, University of California, Los Angeles, CA 90025, USA
    J Allergy Clin Immunol 118:1075-81. 2006
    ..It is currently unclear whether the small airways (diameter <2 microm) contribute significantly to late asthmatic reactions to inhaled allergen...
  27. ncbi request reprint Addition of ibuprofen to pseudoephedrine and chlorpheniramine in the treatment of seasonal allergic rhinitis
    Eli O Meltzer
    Allergy and Asthma Medical Group and Research Center, San Diego, California, USA
    Ann Allergy Asthma Immunol 93:452-9. 2004
    ..Standard over-the-counter therapy with antihistamines and nasal decongestants often does not completely relieve all symptoms associated with allergic rhinitis...
  28. ncbi request reprint Efficacy of once-daily desloratadine/pseudoephedrine for relief of nasal congestion
    Eric Schenkel
    Valley Clinical Research Center, 3729 Easton Nazareth Highway, Suite 202, Easton, PA 18045, USA
    Allergy Asthma Proc 23:325-30. 2002
    ..It was concluded that desloratadine/pseudoephedrine offers additional benefit to patients with moderate-to-severe SAR-associated nasal congestion compared with pseudoephedrine therapy alone...
  29. ncbi request reprint Incidence and characteristics of angioedema associated with enalapril
    John B Kostis
    Department of Medicine, University of Medicine and Dentistry of New Jersey Robert Wood Johnson Medical School, New Brunswick 08903 0019, USA
    Arch Intern Med 165:1637-42. 2005
    ..Angioedema is a rare but potentially serious adverse event of angiotensin-converting enzyme inhibitor therapy. However, no prospective, controlled studies have reported on its incidence and clinical characteristics...
  30. ncbi request reprint The rhinitis-asthma link revisited
    Jonathan Corren
    Ann Allergy Asthma Immunol 94:311-2. 2005